Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
597 |
|
| Actual shortage: | 85 (14%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 494 (83%) | |
Discontinuation Reports |
69 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (74%) | |
| Reversed: | 11 (16%) | |
Late reports |
53 (8%) |
|
Overdue reports |
49 (52%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TADALAFIL | 20MG | TABLET | Actual shortage | 2025-04-07 | 2025-05-02 | 254379 |
| TADALAFIL | 20MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200474 |
| TADALAFIL | 5MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200477 |
| TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-22 | 2024-07-05 | 211102 |
| TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-17 | 2024-02-29 | 216290 |
| TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-20 | 2024-06-07 | 222839 |
| TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-06-18 | 2024-12-05 | 230839 |
| TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-11-18 | 2024-11-19 | 243280 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2024-03-25 | 2024-08-01 | 223276 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2019-04-09 | 2019-05-16 | 80866 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2019-06-10 | 2019-07-20 | 86050 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2019-11-21 | 2020-02-04 | 99483 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2020-02-27 | 2020-03-19 | 107302 |
| TELMISARTAN | 80MG | TABLET | Resolved | 2020-02-27 | 2020-03-19 | 107305 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2020-03-20 | 2020-05-12 | 109140 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2020-03-26 | 2020-05-12 | 109445 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2020-07-08 | 2020-10-21 | 119744 |
| TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Resolved | 2019-05-06 | 2019-06-08 | 83138 |
| TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2019-06-10 | 2019-06-28 | 86053 |
| TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Resolved | 2019-11-21 | 2019-11-28 | 99486 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |